🇺🇸 FDA
Patent

US 10246707

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

granted A61KA61K48/00A61P

Quick answer

US patent 10246707 (Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means) held by BIOMARIN TECHNOLOGIES B.V. expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN TECHNOLOGIES B.V.
Grant date
Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K48/00, A61P, A61P21/00, A61P21/04